Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Carboplatin, Topotecan, and G-CSF in Extensive SCLC
NCT00004137Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Oct 1999
- Primary completion
- Mar 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin, topotecan in small cell lung cancer (SCLC), sponsored by SWOG Cancer Research Network. Started Oct 1999; status: completed.
02
Drugs
paclitaxelcarboplatintopotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00004137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004137.